A case of combined hepatocellular-cholangiocarcinoma with favorable response to systemic chemotherapy.

scientific article published on 31 December 2010

A case of combined hepatocellular-cholangiocarcinoma with favorable response to systemic chemotherapy. is …
instance of (P31):
case reportQ2782326
scholarly articleQ13442814

External links are
P356DOI10.4143/CRT.2010.42.4.235
P932PMC publication ID3021743
P698PubMed publication ID21253326
P5875ResearchGate publication ID49772852

P50authorSang Joon ShinQ63853521
P2093author name stringDokyung Kim
Gun Min Kim
Hei-Cheul Jeung
Eun Suk Jung
Joo Hoon Kim
Sang Hyun Yoon
P2860cites workClinicopathologic features and prognosis of combined hepatocellular cholangiocarcinoma.Q53626745
Combined hepatocellular and cholangiocarcinoma: a clinicopathologic study of 26 resected casesQ73797012
[Combined hepatocellular carcinoma and cholangiocellular carcinoma]Q77403965
Combined hepatocellular and cholangiocarcinoma: demographic, clinical, and prognostic factorsQ77879718
Combined hepatocellular and cholangiocarcinoma: clinical features and prognostic study in a Thai populationQ79397825
Liver transplantation for combined hepatocellular cholangiocarcinomaQ80256706
Potentiality of combined hepatocellular and intrahepatic cholangiocellular carcinoma originating from a hepatic precursor cell: Immunohistochemical evidenceQ81738328
Ablative therapy for liver tumoursQ30542664
Multi-disciplinary treatment for cholangiocellular carcinomaQ34099099
Management of combined hepatocellular and cholangiocarcinoma.Q37088469
Combined hepatocellular-cholangiocarcinoma. A histologic and immunohistochemical studyQ38381235
Surgical treatments and prognoses of patients with combined hepatocellular carcinoma and cholangiocarcinomaQ38497061
Combined liver cell and bile duct carcinoma.Q41980432
A clinicopathological study on combined hepatocellular and cholangiocarcinomaQ43657340
A 42-month disease free survival case of combined hepatocellular-cholangiocarcinoma with lymph node metastases treated with multimodal therapyQ44010955
P275copyright licenseCreative Commons Attribution-NonCommercial 3.0 UnportedQ18810331
P6216copyright statuscopyrightedQ50423863
P433issue4
P921main subjectcholangiocarcinomaQ124292
chemotherapyQ974135
P304page(s)235-238
P577publication date2010-12-31
P1433published inCancer Research and TreatmentQ18411021
P1476titleA case of combined hepatocellular-cholangiocarcinoma with favorable response to systemic chemotherapy
P478volume42

Reverse relations

cites work (P2860)
Q40621862Biphenotypic Primary Liver Carcinomas: Assessing Outcomes of Hepatic Directed Therapy.
Q60928177Combined hepatocellular cholangiocarcinoma (cHCC-CC): an update of genetics, molecular biology, and therapeutic interventions
Q26749446Combined hepatocellular cholangiocarcinoma: Controversies to be addressed
Q58101989Combined hepatocellular-cholangiocarcinoma successfully treated with sorafenib: case report and review of the literature
Q36498935Management of combined hepatocellular-cholangiocarcinoma: a case report and literature review
Q57112805Multicenter retrospective analysis of systemic chemotherapy for unresectable combined hepatocellular and cholangiocarcinoma
Q33593200Systemic therapy for unresectable, mixed hepatocellular-cholangiocarcinoma: treatment of a rare malignancy
Q99352179Therapy of Primary Liver Cancer
Q44808185Transplantation versus resection for patients with combined hepatocellular carcinoma-cholangiocarcinoma
Q90736364Treatment of Combined Hepatocellular and Cholangiocarcinoma
Q38825699Yttrium-90 Radioembolization for Unresectable Combined Hepatocellular-Cholangiocarcinoma

Search more.